DFFN News and Press, Diffusion Pharmaceuticals Inc.

2023-08-16 13:38:03 ET Gainers: EBET ( EBET ) +160% . Novo Integrated Sciences ( NVOS ) +71% . Tivic Health Systems ( TIVC ) +58% . WeTrade Group ( WETG ) +43%. DLocal Limited ( DLO ) +35% . JX Luxventure Limited ( JXJT )...

Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) is one of today's top gainers. The company's shares are currently up 15.2% on the day to $4.6. Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product...

2023-08-15 18:30:34 ET More on Diffusion Pharmaceuticals Diffusion to merge with EIP Pharma in all-stock deal Diffusion to undertake strategic review, options may include company sale Diffusion raised to Buy at H.C. Wainwright after Q2 update on lead asset Fo...

Approximately 71% of Stockholders Voted in Favor of the Transaction Diffusion Announces 1-for-1.5 Reverse Stock Split Merger on Track to Close on August 16, 2023 CHARLOTTESVILLE, Va., Aug. 15, 2023 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) today announced...

NEW YORK, NY / ACCESSWIRE / April 14, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Univar Solutions Inc. (NYSE:UNVR)'s ...

NEW YORK, NY / ACCESSWIRE / March 30, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Diffusion Pharmaceuticals Inc. (NASD...

NEW YORK, NY / ACCESSWIRE / March 30, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: U.S. Xpress Enterprises, Inc. (NYSE:...

2023-03-30 09:32:18 ET Diffusion Pharmaceuticals ( NASDAQ: DFFN ) is merging with privately held EIP Pharma in an all-stock deal. The combined company — which is expected to be renamed as CervoMed and trade under a new ticker, CRVO — will fo...

Combined company will pursue late-stage clinical development of oral neflamapimod for the treatment of dementia with Lewy bodies EIP Pharma to initiate in 2Q 2023 a Phase 2b clinical study, funded in part by a $21 million grant from the National Institute of Aging Combined compa...

LifeSci Special Opportunities Master Fund Announces Support for Diffusion’s Ongoing, Board-led Strategic Review Process and for Diffusion’s Nominees at 2022 Annual Meeting New Director to be Appointed to Diffusion Board if Strategic Transaction Not Completed by mid-2023 ...